GSK is forecast to grow earnings and revenue by 22.4% and 3.9% per annum respectively. EPS is expected to grow by 22.1% per annum. Return on equity is forecast to be 28.7% in 3 years.
Key information
22.4%
Earnings growth rate
22.1%
EPS growth rate
Pharmaceuticals earnings growth
19.6%
Revenue growth rate
3.9%
Future return on equity
28.7%
Analyst coverage
Good
Last updated
13 Nov 2024
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
BOVESPA:G1SK34 - Analysts future estimates and past financials data (GBP Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2026
34,338
6,487
6,489
9,537
16
12/31/2025
32,451
5,802
5,615
8,483
17
12/31/2024
31,271
3,544
3,962
6,617
17
9/30/2024
31,311
2,511
4,917
7,421
N/A
6/30/2024
31,446
4,033
5,222
7,479
N/A
3/31/2024
30,740
4,484
5,330
7,673
N/A
12/31/2023
30,328
4,928
4,436
6,768
N/A
9/30/2023
29,652
6,078
3,247
5,477
N/A
6/30/2023
29,334
5,373
2,486
4,586
N/A
3/31/2023
29,085
4,455
2,892
4,914
N/A
12/31/2022
29,324
4,461
5,341
7,403
N/A
9/30/2022
29,024
3,387
7,620
9,265
N/A
6/30/2022
27,822
3,505
8,073
10,506
N/A
3/31/2022
26,731
4,013
7,611
10,163
N/A
12/31/2021
24,696
3,316
5,939
7,952
N/A
9/30/2021
26,359
3,567
6,064
8,040
N/A
6/30/2021
28,378
3,934
4,871
6,339
N/A
3/31/2021
30,164
4,983
7,028
7,807
N/A
12/31/2020
24,354
4,873
6,839
8,441
N/A
9/30/2020
34,259
6,371
6,833
8,039
N/A
6/30/2020
34,998
6,679
8,751
9,693
N/A
3/31/2020
35,183
5,380
6,628
8,322
N/A
12/31/2019
33,754
4,645
6,261
8,020
N/A
9/30/2019
33,052
4,561
6,832
8,686
N/A
6/30/2019
31,759
4,427
6,488
8,248
N/A
3/31/2019
31,260
3,904
6,735
8,221
N/A
12/31/2018
30,821
3,623
6,881
8,421
N/A
9/30/2018
30,263
1,862
5,521
7,171
N/A
6/30/2018
30,014
1,656
N/A
6,991
N/A
3/31/2018
30,024
1,035
N/A
6,637
N/A
12/31/2017
30,186
1,532
N/A
6,918
N/A
9/30/2017
30,133
2,335
N/A
7,040
N/A
6/30/2017
29,832
1,931
N/A
6,910
N/A
3/31/2017
29,044
1,676
N/A
7,138
N/A
12/31/2016
27,889
912
N/A
6,497
N/A
9/30/2016
26,589
301
N/A
5,007
N/A
6/30/2016
25,174
31
N/A
3,721
N/A
3/31/2016
24,530
615
N/A
2,702
N/A
12/31/2015
23,923
8,422
N/A
2,569
N/A
9/30/2015
23,823
9,809
N/A
3,278
N/A
6/30/2015
23,342
9,672
N/A
4,070
N/A
3/31/2015
23,015
10,177
N/A
4,619
N/A
12/31/2014
23,006
2,756
N/A
5,176
N/A
9/30/2014
23,726
4,184
N/A
5,153
N/A
6/30/2014
24,590
4,752
N/A
5,957
N/A
3/31/2014
25,647
5,143
N/A
6,902
N/A
12/31/2013
26,505
5,436
N/A
7,222
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: G1SK34's forecast earnings growth (22.4% per year) is above the savings rate (10.4%).
Earnings vs Market: G1SK34's earnings (22.4% per year) are forecast to grow faster than the BR market (13.1% per year).
High Growth Earnings: G1SK34's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: G1SK34's revenue (3.9% per year) is forecast to grow slower than the BR market (7.5% per year).
High Growth Revenue: G1SK34's revenue (3.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: G1SK34's Return on Equity is forecast to be high in 3 years time (28.7%)